Amicogen Inc (092040) — Capital Reinvestment Ratio

Latest as of December 2025: 0.10x

Amicogen Inc (092040) has a Capital Reinvestment Ratio of 0.10x as of December 2025, meaning it reinvests 0% of its operating cash flow (₩1.11 Billion) in capital expenditures (₩113.49 Million). Check how tangible is Amicogen Inc's equity to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

0.10x
Capex / Operating Cash Flow

Operating Cash Flow

₩1.11 Billion
KRW

Capital Expenditures

₩113.49 Million
KRW

Data as of

Dec 2025
Most recent filing

Amicogen Inc Capital Reinvestment Ratio (2014–2023)

This chart tracks Amicogen Inc's Capital Reinvestment Ratio across 9 annual periods. For the full cash flow conversion analysis, see Amicogen Inc (092040) cash flow conversion.

Annual Capital Reinvestment Ratio for Amicogen Inc (2014–2023)

Year-by-year Capital Reinvestment Ratio for Amicogen Inc from 2014 to 2023. See 092040 free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.

Year Reinvestment Ratio Operating CF (KRW) Capital Expenditures YoY Change
2023 7.24x ₩8.64 Billion ₩62.60 Billion ▲ +23.6%
2021 5.86x ₩8.07 Billion ₩47.31 Billion ▲ +275.0%
2020 1.56x ₩8.87 Billion ₩13.85 Billion ▼ -28.9%
2019 2.20x ₩8.76 Billion ₩19.26 Billion ▼ -42.6%
2018 3.83x ₩2.84 Billion ₩10.88 Billion ▲ +297.7%
2017 0.96x ₩11.88 Billion ₩11.45 Billion ▼ -35.9%
2016 1.50x ₩11.28 Billion ₩16.95 Billion ▲ +153.4%
2015 0.59x ₩12.34 Billion ₩7.32 Billion ▼ -42.9%
2014 1.04x ₩4.43 Billion ₩4.60 Billion
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow